标题
Melanoma: Where we are and where we go
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 234, Issue 4, Pages 3307-3320
出版商
Wiley
发表日期
2018-10-26
DOI
10.1002/jcp.27286
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
- (2018) S. Valpione et al. EUROPEAN JOURNAL OF CANCER
- Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers
- (2018) Leila Jamali et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Liquid biomarkers in melanoma: detection and discovery
- (2018) Su Yin Lim et al. Molecular Cancer
- miRNA-based strategy for modulation of influenza A virus infection
- (2018) Mohsen Keshavarz et al. Epigenomics
- Molecular Imaging and Oral Cancer Diagnosis and Therapy
- (2017) Maryam Keshavarzi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis
- (2017) Bahman Rashidi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?
- (2017) Hamed Mirzaei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma
- (2017) Stefano Fogli et al. TUMOR BIOLOGY
- Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia
- (2016) S Fathullahzadeh et al. CANCER GENE THERAPY
- Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma
- (2016) M Mohammadi et al. CANCER GENE THERAPY
- Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
- (2016) L Saadatpour et al. CANCER GENE THERAPY
- Circulating melanoma exosomes as diagnostic and prognosis biomarkers
- (2016) Estibaliz Alegre et al. CLINICA CHIMICA ACTA
- Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
- (2016) Hamed Mirzaei et al. CURRENT MEDICINAL CHEMISTRY
- Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
- (2016) Hamed Mirzaei et al. CURRENT MEDICINAL CHEMISTRY
- Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
- (2016) Hamid Mirzaei et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
- (2016) Hamed Mirzaei et al. EUROPEAN JOURNAL OF CANCER
- Curcumin: A new candidate for melanoma therapy?
- (2016) Hamed Mirzaei et al. INTERNATIONAL JOURNAL OF CANCER
- SiRNA and epigenetic aberrations in ovarian cancer
- (2016) HamidReza Mirzaei et al. Journal of Cancer Research and Therapeutics
- Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients
- (2015) Sharon K. Huang et al. Molecular Oncology
- PET/CT, MR, and PET/MR in Lymphoma and Melanoma
- (2015) Nina F. Schwenzer et al. SEMINARS IN NUCLEAR MEDICINE
- Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma
- (2015) Irfan A Asangani et al. Oncotarget
- Evaluation of the Role of Routine Melan-A Immunohistochemistry for Exclusion of Microinvasion in 120 Cases of Lentigo Maligna
- (2014) Ravi Suchak et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- microRNA-340 as a modulator of RAS–RAF–MAPK signaling in melanoma
- (2014) Ashley M. Poenitzsch Strong et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses
- (2014) Bharat Aggarwal et al. MOLECULES
- The malignant melanoma landscape
- (2014) Rachel M. Webster et al. NATURE REVIEWS DRUG DISCOVERY
- Novel anti-melanoma treatment: focus on immunotherapy
- (2014) Meng-Ze Hao et al. Chinese Journal of Cancer
- Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics
- (2013) Jiezhong Chen et al. International Journal of Nanomedicine
- Guidelines of care for the management of primary cutaneous melanoma
- (2013) Timothy M. Johnson JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
- (2013) Altaf A Dar et al. JNCI-Journal of the National Cancer Institute
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule
- (2013) HE-FEI WANG et al. ONCOLOGY REPORTS
- miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
- (2013) Nadia Felli et al. PLoS One
- Nurse-led follow-up care for cancer patients: what is known and what is needed
- (2013) Jacqueline de Leeuw et al. SUPPORTIVE CARE IN CANCER
- A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms
- (2012) Pedram Gerami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
- (2012) Y Xu et al. BRITISH JOURNAL OF CANCER
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells
- (2012) Shunsuke Noguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma
- (2012) Leila Khoja et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)
- (2012) Steven N. Reuland et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serum microRNAs as biomarkers for recurrence in melanoma
- (2012) Erica B Friedman et al. Journal of Translational Medicine
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma
- (2012) A Bhattacharya et al. ONCOGENE
- miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis
- (2011) Avital Gaziel-Sovran et al. CANCER CELL
- The use of immunocytochemical study in the cytologic diagnosis of melanoma: Evaluation of three antibodies
- (2011) Xin Jing et al. DIAGNOSTIC CYTOPATHOLOGY
- Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma
- (2011) Tung Nguyen et al. Epigenetics
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma
- (2011) Shujing Liu et al. JOURNAL OF PATHOLOGY
- Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
- (2011) Chor Sang Chim et al. Journal of Translational Medicine
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
- (2011) L Sun et al. ONCOGENE
- Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma
- (2011) Gianfranco Mattia et al. Pigment Cell & Melanoma Research
- Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma
- (2011) Saray Lorda Mayayo et al. VETERINARY JOURNAL
- MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
- (2010) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- High-throughput miRNA profiling of human melanoma blood samples
- (2010) Petra Leidinger et al. BMC CANCER
- MicroRNAs miR-199a-5p and -3p Target the Brm Subunit of SWI/SNF to Generate a Double-Negative Feedback Loop in a Variety of Human Cancers
- (2010) K. Sakurai et al. CANCER RESEARCH
- Epigenetic inactivation of the miR-34a in hematological malignancies
- (2010) C.S. Chim et al. CARCINOGENESIS
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
- (2010) M. F. Segura et al. CLINICAL CANCER RESEARCH
- Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma
- (2010) Carmit Levy et al. MOLECULAR CELL
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-148 Regulates Mitf in Melanoma Cells
- (2010) Benedikta S. Haflidadóttir et al. PLoS One
- MicroRNA-dependent regulation of cKit in cutaneous melanoma
- (2009) O. Igoucheva et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress
- (2009) M. E. Crosby et al. CANCER RESEARCH
- Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma
- (2009) M. Kitago et al. CLINICAL CANCER RESEARCH
- An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
- (2009) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CpG island methylation profiling in human melanoma cell lines
- (2009) Carmen S. Tellez et al. MELANOMA RESEARCH
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
- (2008) F. Felicetti et al. CANCER RESEARCH
- Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland
- (2008) Tadeusz Dębniak et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
- (2008) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
- (2008) Michael B. Atkins et al. JOURNAL OF CLINICAL ONCOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Biopsy for Malignant Melanoma – Are We Following the Guidelines?
- (2008) S Tadiparthi et al. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started